Phase 1 Study to Evaluate the Safety and Tolerability of 8M2D in Healthy People and Alzheimer's Patients
Clinical trial NCT07568041 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07568041
- Sponsor
- Cenna Biosciences Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-15
- Primary completion
- 2027-09-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.